23andme Holding Co (ME) - News Archive

: 23andMe, a prominent player in genetics and preventive health, recently announced several developments that highlight its commitment to both consumer genetics and collaborations aimed at advancing precision medicine....

23andMe s Board Rejects CEO Acquisition Proposal Amidst Years of Share Price Turbulence Post Reverse SplitIn a notable development in the ongoing saga of 23andMe Holding Co. on March 3, 2025, the Special Committee of th...

23andMe Holding Co. a leader in personal genomics and biotechnology, has made significant advancements in the services it offers to its premium members while concurrently implementing strategic corporate financial adjus...

: In a significant development in the fields of genetics and precision medicine, 23andMe Holding Co. has announced a strategic research collaboration with Mirador Therapeutics on November 20, 2024. This partnership aims...

23andMe’s Strategic Maneuvers: Regaining Nasdaq Compliance Amidst Corporate RestructuringIn a compelling demonstration of resilience and strategic foresight, 23andMe Holding Co. (Nasdaq: ME) has successfully maneuvered...

23andMe Implements 1-for-20 Reverse Stock Split: A Strategic Move Amid CEO s Take-Private ProposalSUNNYVALE, Calif. October 16, 2024 In a significant corporate maneuver, 23andMe Holding Co. (Nasdaq: ME) has completed it...

23andMe to Undergo Significant Financial Restructuring with Reverse Stock SplitIn a strategic move aimed at consolidating its market presence, 23andMe Holding Co. (Nasdaq: ME) has announced a 1-for-20 reverse stock spli...

23andMe Enhances Brand Awareness with Mathew Knowles Collaboration Amidst Improving Financial Metrics 23andMe, a leading personal genomics and biotechnology company, has announced the appointment of Mathew Knowles as it...

In an age where genetics and personal wellness increasingly intersect, biotechnology pioneer 23andMe has unveiled an innovative genetic report aimed at elucidating the likelihood of emotional eating among its 23andMe+ P...

In recent developments within precision medicine, 23andMe Therapeutics has announced significant progress in its clinical research endeavors, particularly regarding cancer treatment and weight management therapies. The...

In recent years, collaborative research efforts spearheaded by 23andMe, often in partnership with prestigious institutions such as the National Human Genome Research Institute and Johns Hopkins University, have yielded...

In the hallowed halls of biomedical discourse, where the delicate dance of science and medicine forswears the mundane for the miraculous, a singular name has emerged from the shadows of apprehension into the radiant lig...

In the ever-evolving landscape of weight management therapies, the recent strategic initiatives by Lemonaid Health and its parent company, 23andMe Holding Co. mark a significant milestone in the integration of genetic s...

In an unexpected turn of events, Anne Wojcicki, the Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe Holding Co., has expressed her interest in acquiring all outstanding shares of the...

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2024 - In a surprising turn of events, leading human genetics and biopharmaceutical company 23andMe Holding Co. has announced a preliminary non-binding indication of interest from i...

In a groundbreaking endeavor aimed at enhancing lung cancer diagnosis and treatment, twenty prominent lung cancer advocacy organizations have joined forces with 23andMe, a pioneering personal genomics and biotechnology...

In a bold move poised to redefine preventive healthcare, 23andMe Holding Co. (Nasdaq: ME) and Nightingale Health Plc have joined forces to test an innovative blood metabolomics panel. This collaboration aims to leverage...

In recent groundbreaking developments, 23andMe Holding Co., a prominent human genetics and biopharmaceutical company, has made significant strides in its mission to revolutionize cancer treatment. The company s latest a...

Largest Study on LRRK2 Variant leads to Discoveries about Health, Ancestry, and History, as 23andMe Continues Expanding Biopharmaceutical EffortsIn a groundbreaking endeavor, leading human genetics and biopharmaceutical...

Fostering their commitment to making prescription medication more accessible and affordable, Lemonaid Health, a leading digital healthcare provider, has recently upped their services game by introducing a powerful erect...